These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16799172)

  • 21. Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial.
    Marty FM; Vidal-Puigserver J; Clark C; Gupta SK; Merino E; Garot D; Chapman MJ; Jacobs F; Rodriguez-Noriega E; Husa P; Shortino D; Watson HA; Yates PJ; Peppercorn AF
    Lancet Respir Med; 2017 Feb; 5(2):135-146. PubMed ID: 28094141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral drugs prophylaxis and treatment of influenza.
    Med Lett Drugs Ther; 2006 Oct; 48(1246):87-8. PubMed ID: 17051136
    [No Abstract]   [Full Text] [Related]  

  • 24. H1N1 influenza in pregnancy: cause for concern.
    Spradlin TL; Clardy BH; Payne EM; Vinson J
    Obstet Gynecol; 2010 Jan; 115(1):185. PubMed ID: 20027058
    [No Abstract]   [Full Text] [Related]  

  • 25. Whatever happened to bird flu?
    Griffiths PD
    Rev Med Virol; 2008; 18(1):1-3. PubMed ID: 18157800
    [No Abstract]   [Full Text] [Related]  

  • 26. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oseltamivir and its active metabolite cross the placenta at significant levels.
    Meijer WJ; Bruinse HW; van den Broek MP; Kromdijk W; Wensing AM
    Clin Infect Dis; 2012 Jun; 54(11):1676-7. PubMed ID: 22460968
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using oseltamivir (Tamiflu) as a first line treatment for seasonal or pandemic flu.
    Greener M
    Nurs Times; 2009 Sep 1-7; 105(34):22. PubMed ID: 19788111
    [No Abstract]   [Full Text] [Related]  

  • 30. Swine influenza: nephrologist's perspective.
    Gupta A; Ignatius A; Khaira A; Agarwal SK
    Iran J Kidney Dis; 2009 Jul; 3(3):175-6. PubMed ID: 19617670
    [No Abstract]   [Full Text] [Related]  

  • 31. [Highly selective virostatic therapy. Influenza wave could have been stopped].
    Leshel-Hauzeneder M
    MMW Fortschr Med; 2003 Mar; 145(13):54-5. PubMed ID: 15101538
    [No Abstract]   [Full Text] [Related]  

  • 32. Zanamivir treatment is equally effective for both influenza A and influenza B.
    Kawai N; Ikematsu H; Iwaki N; Tanaka O; Yamanishi Y; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2007 Jun; 44(12):1666. PubMed ID: 17516418
    [No Abstract]   [Full Text] [Related]  

  • 33. General practitioners' management of influenza with or without neuraminidase inhibitors.
    Carrat F; El Sawi A; Grandmottet G; Schlemmer C; Gaillat J
    Eur J Gen Pract; 2007; 13(3):157-9. PubMed ID: 17853179
    [No Abstract]   [Full Text] [Related]  

  • 34. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiinfluenza medication kits need work, FDA advisers conclude.
    Traynor K
    Am J Health Syst Pharm; 2008 Dec; 65(24):2314-6. PubMed ID: 19052270
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and children.
    Standing JF; Tsolia M; Lutsar I
    Infect Disord Drug Targets; 2013 Feb; 13(1):6-14. PubMed ID: 23675922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 38. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The war against influenza: discovery and development of sialidase inhibitors.
    von Itzstein M
    Nat Rev Drug Discov; 2007 Dec; 6(12):967-74. PubMed ID: 18049471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of zanamivir following intravenous administration to subjects with and without renal impairment.
    Weller S; Jones LS; Lou Y; Peppercorn A; Ng-Cashin J
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2967-71. PubMed ID: 23587959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.